blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2836213

EP2836213 - FUSED GAMMA CARBOLINES [Right-click to bookmark this link]
Former [2015/08]ORGANIC COMPOUNDS
[2018/04]
StatusNo opposition filed within time limit
Status updated on  10.05.2019
Database last updated on 29.06.2024
FormerThe patent has been granted
Status updated on  01.06.2018
FormerGrant of patent is intended
Status updated on  24.01.2018
Most recent event   Tooltip01.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 03.08.2022  [2022/31]
Applicant(s)For all designated states
Intra-Cellular Therapies, Inc.
430 East 29th Street, Suite 900
New York, NY 10016 / US
[2016/33]
Former [2015/08]For all designated states
Intra-Cellular Therapies, Inc.
3960 Broadway
New York, NY 10032 / US
Inventor(s)01 / MATES, Sharon
Intra-Cellular Therapies Inc.
3960 Broadway
New York, New York 10032 / US
02 / DAVIS, Robert
Intra-Cellular Therapies Inc.
3960 Broadway
New York, New York 10032 / US
03 / LI, Peng
Intra-Cellular Therapies Inc.
3960 Broadway
New York, New York 10032 / US
04 / WENNOGLE, Lawrence
Intra-Cellular Therapies Inc.
3960 Broadway
New York, New York 10032 / US
05 / LERNER, Richard A.
Intra-Cellular Therapies Inc.
3960 Broadway
New York, New York 10032 / US
 [2015/08]
Representative(s)McNab, Donald C., et al
Marks & Clerk LLP
40 Torphichen Street
Edinburgh EH3 8JB / GB
[2018/27]
Former [2015/08]McNab, Donald C.
Marks & Clerk LLP
Atholl Exchange
6 Canning Street
Edinburgh EH3 8EG / GB
Application number, filing date13776297.714.04.2013
[2018/27]
WO2013US36514
Priority number, dateUS201261624293P14.04.2012         Original published format: US 201261624293 P
US201261624292P14.04.2012         Original published format: US 201261624292 P
US201261624291P14.04.2012         Original published format: US 201261624291 P
US201261671723P14.07.2012         Original published format: US 201261671723 P
US201261671713P14.07.2012         Original published format: US 201261671713 P
[2015/08]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013155505
Date:17.10.2013
Language:EN
[2013/42]
Type: A1 Application with search report 
No.:EP2836213
Date:18.02.2015
Language:EN
The application published by WIPO in one of the EPO official languages on 17.10.2013 takes the place of the publication of the European patent application.
[2015/08]
Type: B1 Patent specification 
No.:EP2836213
Date:04.07.2018
Language:EN
[2018/27]
Search report(s)International search report - published on:US17.10.2013
(Supplementary) European search report - dispatched on:EP06.08.2015
ClassificationIPC:A01N43/42, A61K31/44, A61P25/18, A61P25/24, A61P25/14, A61P25/20, C07D471/14
[2018/04]
CPC:
A61K31/445 (EP,US); A61K31/4985 (EP,CN,US); C07D471/14 (US);
A61K31/5383 (EP,US); A61K45/06 (EP,US); A61P21/02 (EP);
A61P25/00 (EP); A61P25/06 (EP); A61P25/14 (EP);
A61P25/16 (EP); A61P25/18 (EP); A61P25/20 (EP);
A61P25/22 (EP); A61P25/24 (EP); A61P25/28 (EP,US);
A61P3/04 (EP); A61P31/00 (EP); A61P43/00 (EP);
C07D471/16 (EP,CN,US) (-)
C-Set:
A61K31/4985, A61K2300/00 (EP,US);
A61K31/5383, A61K2300/00 (US,EP)
Former IPC [2015/37]A01N43/42, A61K31/44, A61P25/18, A61P25/24, A61P25/14, A61P25/20
Former IPC [2015/08]A61K31/4985
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2015/08]
Extension statesBA04.11.2014
ME04.11.2014
TitleGerman:KONDENSIERTE GAMMA CARBOLINE[2018/04]
English:FUSED GAMMA CARBOLINES[2018/04]
French:GAMMA CARBOLINES FUSIONNÉES[2018/04]
Former [2015/08]ORGANISCHE VERBINDUNGEN
Former [2015/08]ORGANIC COMPOUNDS
Former [2015/08]COMPOSÉS ORGANIQUES
Entry into regional phase04.11.2014National basic fee paid 
04.11.2014Search fee paid 
04.11.2014Designation fee(s) paid 
04.11.2014Examination fee paid 
Examination procedure04.11.2014Examination requested  [2015/08]
01.06.2015Amendment by applicant (claims and/or description)
25.01.2018Communication of intention to grant the patent
22.05.2018Fee for grant paid
22.05.2018Fee for publishing/printing paid
22.05.2018Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  25.01.2018
Opposition(s)05.04.2019No opposition filed within time limit [2019/24]
Fees paidRenewal fee
10.04.2015Renewal fee patent year 03
11.04.2016Renewal fee patent year 04
10.04.2017Renewal fee patent year 05
11.04.2018Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU14.04.2013
AL04.07.2018
AT04.07.2018
CY04.07.2018
CZ04.07.2018
DK04.07.2018
EE04.07.2018
ES04.07.2018
FI04.07.2018
HR04.07.2018
IT04.07.2018
LT04.07.2018
LV04.07.2018
MC04.07.2018
MK04.07.2018
MT04.07.2018
NL04.07.2018
PL04.07.2018
RO04.07.2018
RS04.07.2018
SE04.07.2018
SI04.07.2018
SK04.07.2018
SM04.07.2018
TR04.07.2018
BG04.10.2018
NO04.10.2018
GR05.10.2018
IS04.11.2018
PT04.11.2018
[2022/31]
Former [2021/34]HU14.04.2013
AL04.07.2018
AT04.07.2018
CY04.07.2018
CZ04.07.2018
DK04.07.2018
EE04.07.2018
ES04.07.2018
FI04.07.2018
HR04.07.2018
IT04.07.2018
LT04.07.2018
LV04.07.2018
MC04.07.2018
MT04.07.2018
NL04.07.2018
PL04.07.2018
RO04.07.2018
RS04.07.2018
SE04.07.2018
SI04.07.2018
SK04.07.2018
SM04.07.2018
TR04.07.2018
BG04.10.2018
NO04.10.2018
GR05.10.2018
IS04.11.2018
PT04.11.2018
Former [2021/32]HU14.04.2013
AL04.07.2018
AT04.07.2018
CY04.07.2018
CZ04.07.2018
DK04.07.2018
EE04.07.2018
ES04.07.2018
FI04.07.2018
HR04.07.2018
IT04.07.2018
LT04.07.2018
LV04.07.2018
MC04.07.2018
NL04.07.2018
PL04.07.2018
RO04.07.2018
RS04.07.2018
SE04.07.2018
SI04.07.2018
SK04.07.2018
SM04.07.2018
TR04.07.2018
BG04.10.2018
NO04.10.2018
GR05.10.2018
IS04.11.2018
PT04.11.2018
Former [2021/26]AL04.07.2018
AT04.07.2018
CY04.07.2018
CZ04.07.2018
DK04.07.2018
EE04.07.2018
ES04.07.2018
FI04.07.2018
HR04.07.2018
IT04.07.2018
LT04.07.2018
LV04.07.2018
MC04.07.2018
NL04.07.2018
PL04.07.2018
RO04.07.2018
RS04.07.2018
SE04.07.2018
SI04.07.2018
SK04.07.2018
SM04.07.2018
TR04.07.2018
BG04.10.2018
NO04.10.2018
GR05.10.2018
IS04.11.2018
PT04.11.2018
Former [2020/29]AL04.07.2018
AT04.07.2018
CZ04.07.2018
DK04.07.2018
EE04.07.2018
ES04.07.2018
FI04.07.2018
HR04.07.2018
IT04.07.2018
LT04.07.2018
LV04.07.2018
MC04.07.2018
NL04.07.2018
PL04.07.2018
RO04.07.2018
RS04.07.2018
SE04.07.2018
SI04.07.2018
SK04.07.2018
SM04.07.2018
TR04.07.2018
BG04.10.2018
NO04.10.2018
GR05.10.2018
IS04.11.2018
PT04.11.2018
Former [2020/16]AL04.07.2018
AT04.07.2018
CZ04.07.2018
DK04.07.2018
EE04.07.2018
ES04.07.2018
FI04.07.2018
HR04.07.2018
IT04.07.2018
LT04.07.2018
LV04.07.2018
MC04.07.2018
NL04.07.2018
PL04.07.2018
RO04.07.2018
RS04.07.2018
SE04.07.2018
SI04.07.2018
SK04.07.2018
SM04.07.2018
TR04.07.2018
BG04.10.2018
NO04.10.2018
GR05.10.2018
IS04.11.2018
Former [2020/02]AL04.07.2018
AT04.07.2018
CZ04.07.2018
DK04.07.2018
EE04.07.2018
ES04.07.2018
FI04.07.2018
HR04.07.2018
IT04.07.2018
LT04.07.2018
LV04.07.2018
MC04.07.2018
NL04.07.2018
PL04.07.2018
RO04.07.2018
RS04.07.2018
SE04.07.2018
SI04.07.2018
SK04.07.2018
SM04.07.2018
BG04.10.2018
NO04.10.2018
GR05.10.2018
IS04.11.2018
Former [2019/37]AL04.07.2018
AT04.07.2018
CZ04.07.2018
DK04.07.2018
EE04.07.2018
ES04.07.2018
FI04.07.2018
HR04.07.2018
IT04.07.2018
LT04.07.2018
LV04.07.2018
NL04.07.2018
PL04.07.2018
RO04.07.2018
RS04.07.2018
SE04.07.2018
SI04.07.2018
SK04.07.2018
SM04.07.2018
BG04.10.2018
NO04.10.2018
GR05.10.2018
IS04.11.2018
Former [2019/26]AL04.07.2018
AT04.07.2018
CZ04.07.2018
DK04.07.2018
EE04.07.2018
ES04.07.2018
FI04.07.2018
HR04.07.2018
IT04.07.2018
LT04.07.2018
LV04.07.2018
NL04.07.2018
PL04.07.2018
RO04.07.2018
RS04.07.2018
SE04.07.2018
SK04.07.2018
SM04.07.2018
BG04.10.2018
NO04.10.2018
GR05.10.2018
IS04.11.2018
Former [2019/24]AL04.07.2018
AT04.07.2018
CZ04.07.2018
EE04.07.2018
ES04.07.2018
FI04.07.2018
HR04.07.2018
IT04.07.2018
LT04.07.2018
LV04.07.2018
NL04.07.2018
PL04.07.2018
RO04.07.2018
RS04.07.2018
SE04.07.2018
SK04.07.2018
BG04.10.2018
NO04.10.2018
GR05.10.2018
IS04.11.2018
Former [2019/22]AL04.07.2018
AT04.07.2018
CZ04.07.2018
ES04.07.2018
FI04.07.2018
HR04.07.2018
IT04.07.2018
LT04.07.2018
LV04.07.2018
NL04.07.2018
PL04.07.2018
RO04.07.2018
RS04.07.2018
SE04.07.2018
BG04.10.2018
NO04.10.2018
GR05.10.2018
IS04.11.2018
Former [2019/21]AL04.07.2018
AT04.07.2018
CZ04.07.2018
ES04.07.2018
FI04.07.2018
HR04.07.2018
IT04.07.2018
LT04.07.2018
LV04.07.2018
NL04.07.2018
PL04.07.2018
RS04.07.2018
SE04.07.2018
BG04.10.2018
NO04.10.2018
GR05.10.2018
IS04.11.2018
Former [2019/12]AL04.07.2018
AT04.07.2018
CZ04.07.2018
ES04.07.2018
FI04.07.2018
HR04.07.2018
LT04.07.2018
LV04.07.2018
NL04.07.2018
PL04.07.2018
RS04.07.2018
SE04.07.2018
BG04.10.2018
NO04.10.2018
GR05.10.2018
IS04.11.2018
Former [2019/11]AT04.07.2018
CZ04.07.2018
FI04.07.2018
HR04.07.2018
LT04.07.2018
NL04.07.2018
PL04.07.2018
RS04.07.2018
SE04.07.2018
BG04.10.2018
NO04.10.2018
GR05.10.2018
IS04.11.2018
Former [2019/10]AT04.07.2018
CZ04.07.2018
FI04.07.2018
LT04.07.2018
NL04.07.2018
PL04.07.2018
RS04.07.2018
SE04.07.2018
BG04.10.2018
NO04.10.2018
GR05.10.2018
IS04.11.2018
Former [2019/08]FI04.07.2018
LT04.07.2018
NL04.07.2018
NO04.10.2018
IS04.11.2018
Former [2019/07]LT04.07.2018
NL04.07.2018
Former [2019/04]NL04.07.2018
Documents cited:Search[Y]WO0077002  (DU PONT PHARM CO [US]);
 [Y]US6552017  (ROBICHAUD ALBERT J [US], et al);
 [Y]US2004220178  (ROBICHAUD ALBERT J [US], et al);
 [Y]WO2008112280  (INTRA CELLULAR THERAPIES INC [US], et al);
 [A]WO2009145900  (INTRA CELLULAR THERAPIES INC [US], et al);
International search[A]US6548493  (ROBICHAUD ALBERT J [US], et al);
 [A]US2011112105  (TOMESCH JOHN [US], et al);
 [A]WO2011133224  (INTRA CELLULAR THERAPIES INC [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.